New drug tested as lifeline for adults with Tough-to-Treat leukemia

This study looked at how well and how safely the drug blinatumomab worked for 92 adults in France with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). The patients had cancer that had come back, did not respond to other treatments, or had small amounts of cancer still present after initial therapy. Researchers tracked survival, response rates, and side effects to see if this drug could help control the disease, often as a step before a stem cell transplant.